Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1992; Volume 41,Issue 2
  • You have access
    Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation.
    J Lerma and R Martín del Río
    Molecular Pharmacology February 1992, 41 (2) 217-222;
  • You have access
    Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    W Y Gao, F S Han, C Storm, W Egan and Y C Cheng
    Molecular Pharmacology February 1992, 41 (2) 223-229;
  • You have access
    Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
    A J Townsend, C P Tu and K H Cowan
    Molecular Pharmacology February 1992, 41 (2) 230-236;
  • You have access
    Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
    X B Kong, L Rubin, L I Chen, G Ciszewska, K A Watanabe, W P Tong, F M Sirotnak and T C Chou
    Molecular Pharmacology February 1992, 41 (2) 237-244;
  • You have access
    Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
    W B Parker, S C Shaddix, P W Allan, G Arnett, L M Rose, W M Shannon, Y F Shealy, J A Montgomery, J A Secrist and L L Bennett
    Molecular Pharmacology February 1992, 41 (2) 245-251;
  • You have access
    Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
    D A Weidner, E G Bridges, E M Cretton and J P Sommadossi
    Molecular Pharmacology February 1992, 41 (2) 252-258;
  • You have access
    Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
    R Hyland, A Gescher, K Thummel, C Schiller, P Jheeta, K Mynett, A W Smith and J Mráz
    Molecular Pharmacology February 1992, 41 (2) 259-266;
  • You have access
    5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.
    J A Mancini, P Prasit, M G Coppolino, P Charleson, S Leger, J F Evans, J W Gillard and P J Vickers
    Molecular Pharmacology February 1992, 41 (2) 267-272;
  • You have access
    Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation.
    B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger
    Molecular Pharmacology February 1992, 41 (2) 273-280;
  • You have access
    Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
    T L Yue, J M Stadel, H M Sarau, E Friedman, J L Gu, D A Powers, M M Gleason, G Feuerstein and H Y Wang
    Molecular Pharmacology February 1992, 41 (2) 281-289;
  • You have access
    Heterogeneity of angiotensin II AT2 receptors in the rat brain.
    K Tsutsumi and J M Saavedra
    Molecular Pharmacology February 1992, 41 (2) 290-297;
  • You have access
    [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
    H G Knaus, J Striessnig, S Hering, S Marrer, E Schwenner, H D Höltje and H Glossmann
    Molecular Pharmacology February 1992, 41 (2) 298-307;
  • You have access
    Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione.
    S W Leslie, L M Brown, R D Trent, Y H Lee, J L Morris, T W Jones, P K Randall, S S Lau and T J Monks
    Molecular Pharmacology February 1992, 41 (2) 308-314;
  • You have access
    Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    R P Mason, D M Moisey and L Shajenko
    Molecular Pharmacology February 1992, 41 (2) 315-321;
  • You have access
    Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.
    J Snyders, K M Knoth, S L Roberds and M M Tamkun
    Molecular Pharmacology February 1992, 41 (2) 322-330;
  • You have access
    Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
    C F Valenzuela, J A Kerr, P Duvvuri and D A Johnson
    Molecular Pharmacology February 1992, 41 (2) 331-336;
  • You have access
    Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    J C Randle, T Guet, C Bobichon, C Moreau, P Curutchet, B Lambolez, L P de Carvalho, A Cordi and J M Lepagnol
    Molecular Pharmacology February 1992, 41 (2) 337-345;
  • You have access
    Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.
    H Ouadid, J Seguin, A Dumuis, J Bockaert and J Nargeot
    Molecular Pharmacology February 1992, 41 (2) 346-351;
  • You have access
    A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
    I Hide, W L Padgett, K A Jacobson and J W Daly
    Molecular Pharmacology February 1992, 41 (2) 352-359;
  • You have access
    Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase.
    A Laurenza, J D Robbins and K B Seamon
    Molecular Pharmacology February 1992, 41 (2) 360-368;
  • You have access
    Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
    J Wess, D Gdula and M R Brann
    Molecular Pharmacology February 1992, 41 (2) 369-374;
  • You have access
    Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells.
    J B Kurz and J P Perkins
    Molecular Pharmacology February 1992, 41 (2) 375-381;
  • You have access
    Quantitative analysis of diacylglycerol second messengers in human platelets: correlation with aggregation and secretion.
    M H Werner, A E Bielawska and Y A Hannun
    Molecular Pharmacology February 1992, 41 (2) 382-386;
  • You have access
    Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates.
    N E Ward and C A O'Brian
    Molecular Pharmacology February 1992, 41 (2) 387-392;
  • You have access
    Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
    R F Kletzien, S D Clarke and R G Ulrich
    Molecular Pharmacology February 1992, 41 (2) 393-398;
  • You have access
    Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay.
    T D Warner, J A Mitchell, P D'Orleans-Juste, K Ishii, U Förstermann and F Murad
    Molecular Pharmacology February 1992, 41 (2) 399-403;
  • You have access
    Lactosylated high density lipoprotein: a potential carrier for the site-specific delivery of drugs to parenchymal liver cells.
    M K Bijsterbosch and T J Van Berkel
    Molecular Pharmacology February 1992, 41 (2) 404-411;
  • You have access
    Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
    H A Berman and K Leonard
    Molecular Pharmacology February 1992, 41 (2) 412-418;
  • You have access
    Direct measurements of the rate constants of sulfonamides with carbonic anhydrase.
    T H Maren
    Molecular Pharmacology February 1992, 41 (2) 419-426;
  • You have access
    Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal.
    E S Roberts, A D Vaz and M J Coon
    Molecular Pharmacology February 1992, 41 (2) 427-433;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 41, Issue 2
1 Feb 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics